Connection
Tim Lahm to Pulmonary Embolism
This is a "connection" page, showing publications Tim Lahm has written about Pulmonary Embolism.
|
|
Connection Strength |
|
 |
|
 |
|
1.466 |
|
|
|
-
Kline JA, Puskarich MA, Jones AE, Mastouri RA, Hall CL, Perkins A, Gundert EE, Lahm T. Inhaled nitric oxide to treat intermediate risk pulmonary embolism: A multicenter randomized controlled trial. Nitric Oxide. 2019 03 01; 84:60-68.
Score: 0.519
-
Kline JA, Hall CL, Jones AE, Puskarich MA, Mastouri RA, Lahm T. Randomized trial of inhaled nitric oxide to treat acute pulmonary embolism: The iNOPE trial. Am Heart J. 2017 04; 186:100-110.
Score: 0.454
-
Lahm T. Large animal studies in pulmonary hypertension--what phenotype do we need to model? J Surg Res. 2012 Nov; 178(1):115-8.
Score: 0.310
-
Millington SJ, Aissaoui N, Bowcock E, Brodie D, Burns KEA, Doufl? G, Haddad F, Lahm T, Piazza G, Sanchez O, Savale L, Vieillard-Baron A. High and intermediate risk pulmonary embolism in the ICU. Intensive Care Med. 2024 Feb; 50(2):195-208.
Score: 0.183
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|